Download PDF
Am J Perinatol 2012; 29(10): 843-844
DOI: 10.1055/s-0032-1329394
Erratum
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Daptomycin Use in a Neonate: Serum Level Monitoring and Outcome

Kosmas Sarafidis
1   1st Department of Neonatology, Aristotle University, Hippokration General Hospital, Thessaloniki, Greece
,
Elias Iosifidis
2   3rd Department of Pediatrics, Aristotle University, Hippokration General Hospital, Thessaloniki, Greece
,
Evangelos Gikas
3   The Goulandris Natural History Museum, GAIA Research Center, Kifissia, Greece
,
Maria Tsivitanidou
4   Department of Microbiology, Hippokration General Hospital, Thessaloniki, Greece
,
Vassiliki Drossou-Agakidou
1   1st Department of Neonatology, Aristotle University, Hippokration General Hospital, Thessaloniki, Greece
,
Emmanuel Roilides
2   3rd Department of Pediatrics, Aristotle University, Hippokration General Hospital, Thessaloniki, Greece
› Author Affiliations
Further Information

Publication History

Publication Date:
18 October 2012 (online)

    Permissions and Reprints

Correction to:

Daptomycin Use in a Neonate: Serum Level Monitoring and OutcomeAm J Perinatol 2010; 27(05): 421-424
DOI: 10.1055/s-0029-1243370

The publisher regrets an error in the abstract in the above article in the American Journal of Perinatology, Volume 27, Number 5, 2010, page 421.

In the abstract, the last sentence with regards to peak and trough serum concentrations of daptomycin should read “Peak and trough serum concentrations of daptomycin were 27.3 and 11.6 μg/mL at day 4 as well as 22.9 and 7.9 μg/mL at day 11 after initiation of treatment, respectively” and not “Peak and trough serum concentrations of daptomycin were 22.9 and 11.6 μg/mL at day 4 as well as 27.3 and 7.9 μg/mL at day 11 after initiation of treatment, respectively”.